ES2122291T3 - Receptor ep3 de la prostaglandina y adn que lo codifica. - Google Patents

Receptor ep3 de la prostaglandina y adn que lo codifica.

Info

Publication number
ES2122291T3
ES2122291T3 ES94918700T ES94918700T ES2122291T3 ES 2122291 T3 ES2122291 T3 ES 2122291T3 ES 94918700 T ES94918700 T ES 94918700T ES 94918700 T ES94918700 T ES 94918700T ES 2122291 T3 ES2122291 T3 ES 2122291T3
Authority
ES
Spain
Prior art keywords
receptor
prostaglandin
dna
codes
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94918700T
Other languages
English (en)
Inventor
Mark Abramovitz
Yves Boie
Kathleen Metters
Thomas H Rushmore
Mohammed Adam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Application granted granted Critical
Publication of ES2122291T3 publication Critical patent/ES2122291T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

UN GRUPO RECEPTOR DE PROSTAGLANDINA NOVEDOSO DEL SUPTIPO EP3 HA SIDO IDENTIFICADO, Y EL DNA QUE CODIFICA AL RECEPTOR HA SIDO AISLADO, PURIFICADO, SECUENCIADO Y EXPRESADO EN CELULAS ANFITRIONAS. EL DNA QUE CODIFICA LOS RECEPTORES NOVEDOSOS Y LAS CELULAS ANFITRIONAS QUE LOS EXPRESAN SE UTILIZAN PARA IDENTIFICAR MODULADORES DE LOS RECEPTORES DE PROSTAGLANDINA.
ES94918700T 1993-06-25 1994-06-09 Receptor ep3 de la prostaglandina y adn que lo codifica. Expired - Lifetime ES2122291T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8374693A 1993-06-25 1993-06-25

Publications (1)

Publication Number Publication Date
ES2122291T3 true ES2122291T3 (es) 1998-12-16

Family

ID=22180426

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94918700T Expired - Lifetime ES2122291T3 (es) 1993-06-25 1994-06-09 Receptor ep3 de la prostaglandina y adn que lo codifica.

Country Status (9)

Country Link
EP (1) EP0705277B1 (es)
JP (1) JP3343258B2 (es)
AT (1) ATE172471T1 (es)
AU (1) AU6991994A (es)
CA (1) CA2165953C (es)
DE (1) DE69414109T2 (es)
DK (1) DK0705277T3 (es)
ES (1) ES2122291T3 (es)
WO (1) WO1995000552A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670134B1 (en) 1993-11-19 2003-12-30 Allergan, Inc. Human EP3 prostaglandin receptor
US6057433A (en) 1993-11-19 2000-05-02 Allergan Sales, Inc. Nucleic acid encoding human EP3 prostaglandin receptor
JP3064015B2 (ja) 1995-01-26 2000-07-12 メルク フロスト カナダ アンド カンパニー プロスタグランジンレセプターｄｐ
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20030157599A1 (en) * 2002-01-30 2003-08-21 Decode Genetics Ehf Gene for peripheral arterial occlusive disease
WO2004074830A2 (en) * 2003-02-24 2004-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 iii (prostaglandin e2 ep3 iii)
WO2004075813A2 (en) * 2003-02-26 2004-09-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii)
WO2004075814A2 (en) * 2003-02-26 2004-09-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 i (prostaglandin e2 ep3 i)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3508865B2 (ja) * 1992-02-24 2004-03-22 周 成宮 プロスタグランジンｅ受容蛋白質、それをコードするｄｎａおよびその製造法

Also Published As

Publication number Publication date
EP0705277B1 (en) 1998-10-21
AU6991994A (en) 1995-01-17
JP3343258B2 (ja) 2002-11-11
ATE172471T1 (de) 1998-11-15
EP0705277A1 (en) 1996-04-10
CA2165953C (en) 2003-08-19
DK0705277T3 (da) 1999-06-28
JPH09500527A (ja) 1997-01-21
CA2165953A1 (en) 1995-01-05
DE69414109D1 (de) 1998-11-26
DE69414109T2 (de) 1999-05-27
WO1995000552A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
ES2192561T3 (es) Adn que codifica el receptor ip de prostaglandina.
ES2120052T3 (es) Receptor de prostaglandina fp y dna que lo codifica.
CA2170509A1 (en) Dna encoding prostaglandin receptor ep2
DE69836088D1 (de) Als lerk6 bezeichnetes cytokin
ES2128457T5 (es) Metalocenos con puente de sililo y su utilizacion.
ES2153037T3 (es) Lacasas purificadas de scytalidium y acidos nucleicos que las codifican.
MX9403899A (es) Adn que codifica al receptor ep1 de prostaglandina
DE69534235D1 (de) Cytokin lerk-7
PT765394E (pt) Lacases myceliophthora purificadas e acidos nucleicos que as codificam
WO1996023066A3 (en) Prostaglandin receptor, dp
SE9301270D0 (sv) Biosensor
ES2122291T3 (es) Receptor ep3 de la prostaglandina y adn que lo codifica.
AR246765A1 (es) Novedosos genes y secuencias de adn del factor i del crecimiento del tipo de la preproinsulina humana.
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
ATE239074T1 (de) Transduktion von menschlichen hämatopoiestischen stammzellen
ITPT910002A0 (it) Procedimento per disgregare i pneumatici usati, onde ottenere il recupero ecologico dei materiali costituenti i pneumatici stessi
NO905545D0 (no) Renset ubiquitinhydrolase, dna-sekvenser som koder for samme, samt anvendelse for isolering av polypeptider.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 705277

Country of ref document: ES